Actively Recruiting
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
Led by Qurasense · Updated on 2026-02-02
450
Participants Needed
4
Research Sites
65 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The EQUIP Study is testing whether high-risk human papillomavirus (hrHPV), the virus that causes most cervical cancers, can be accurately detected from menstrual blood collected at home. People who have been referred for colposcopy after an abnormal Pap or hrHPV test will use the Q-Pad Kit during their period to collect menstrual samples on a special menstrual pad and mail them to a central laboratory for hrHPV testing. The same participants will have a standard cervical sample collected for routine hrHPV testing and will undergo colposcopy as part of their usual care. By comparing hrHPV results from menstrual samples with results from cervical samples and biopsy findings, the study will evaluate how well the Q-Pad hrHPV Test System detects cervical precancer and will also assess how easy and acceptable it is for participants to use this at-home collection method.
CONDITIONS
Official Title
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- You are 25 years old or older and have an intact cervix.
- You were referred for a colposcopy after an abnormal Pap or HPV screen.
- Your periods come regularly-about every 21-35 days.
- You own a smartphone, have an email address, and can read the Qvin app instructions in English.
- You are willing to sign the consent form (electronically).
- You agree to use a condom for any vaginal intercourse or shared penetrative toy use from Q-Pad collection until the colposcopy visit if engaging with a new sexual partner during this period.
You will not qualify if you...
- You are pregnant or think you might be.
- You are unwilling or unable to use the two Q-Pads and mail them back (mailing costs are covered).
- You had treatment for cervical pre-cancer (CIN2+)-such as LEEP, cone, or ablation-within the last 12 months.
- You have already joined this study or are in another cervical-screening / HPV study right now.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Planned Parenthood of Southern New England
New Haven, Connecticut, United States, 06511
Actively Recruiting
2
Planned Parenthood North Central States
Minneapolis, Minnesota, United States, 55408
Actively Recruiting
3
Planned Parenthood of Greater Ohio (PPGOH)
Akron, Ohio, United States, 44302
Actively Recruiting
4
Planned Parenthood Association of Utah
Salt Lake City, Utah, United States, 84102
Actively Recruiting
Research Team
B
Brian Weinberg, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here